期刊文献+

丙基硫氧嘧啶致肺血管炎1例报告及讨论 被引量:3

Propylthiouracil Induced Pulmonary Vasculitis in 1 Patient
下载PDF
导出
摘要 血管炎是丙基硫氧嘧啶的一种少见的药物不良反应,常累及皮肤和肾脏,肺部合并症罕见。本文报道的一例丙基硫氧嘧啶所致的抗中性粒细胞胞浆抗体(ANCA)阳性血管炎患者却仅有肺部受累表现,并在病程中出现呼吸衰竭。作者对其进行了纤维支气管镜及支气管透壁肺活检等检查。该例患者血中和支气管肺泡灌洗液中均检测到ANCA阳性,且非常见抗原类型,作者又对其抗原特异性进一步进行了分析。经停药并加用糖皮质激素治疗后,该患者症状完全消失。 Propylthiouracil (PTU) is known to cause vasculitis as a rare complication. The pulmonary complications are extremely rare. This paper reports the case of patient who developed diffused interstitial pneumonitis and respiratory failure without other systemic complications whilst treated with PTU. Flbrobronchoscopy and trans-bronchial lung biopsy was made. The serum and bronchoalveolar lavage fluid were all positive for antineutrophil cytoplasmic antibody (ANCA) without specificity to myeloperoxidase (MPO) and proteinase 3 (PR3). Its specificity was analyze to other 5 components of ANCA. All symptoms resolved completely after discontinuation of PTU and corticosteroid therapy.
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2003年第3期233-236,共4页 The Chinese Journal of Clinical Pharmacology
关键词 丙基硫氧嘧啶 肺血管炎 药物不良反应 抗中性粒细胞胞浆抗体 抗甲状腺药物 propylthiouracil antineutrophil cytoplasmic antibody vasculitis
  • 相关文献

参考文献11

  • 1Choi HK, Merkel PA, Walker AM, et al. Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: Prevalence among patients with high titers of antimyeloperoxidase antibodies.Arthritis Rheum, 2000;43:405 -- 13.
  • 2Noh KY, Asari T, Hamada N, et aL Frequency of appearance of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) in Graves' disease patients treated with propylthiouracil and the relationship between MPO-ANCA and clinical manifestations. Clin Endocrinol, 2001,54:651 - 654.
  • 3Gunton JE, Stiel J, Clifton-Bligh P, et al. Prevalence of positive anti-neutrophil cytoplasmic antibody (ANCA) in patients receiving anti-thyroid medication. Eur J Endocrinol, 2000;142:587.
  • 4Dolman KM, Crans RO, Vervaat TJ, et al. Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy. Lancet, 1993;342:651-652.
  • 5Savige J, Davies D, Falk R J, et al. Antineutrophil cytoplasmic antibodies and associated diseases: a review of the clinical and laboratory features. Kedney Int, 2000;57:846-862.
  • 6Ohtsuka M, Yamashita Y, Doi M, et al. Propylthiouracil-induced alveolar heamorrhage associated with antineutrophil cytoplasmic antibody. Eur Respir J, 1997; 10:1405 -- 1407.
  • 7Chevrolet JC, Guelpa G, Schifferli JA. Recurrent adult respiratory distress-like syndrome associated with propylthiouracil therapy.Eur Respir J, 1991;4:899 --901.
  • 8Miyazono K, Okazaki T, Uchida S, et al. Propylthiouracil-induced diffuse intersdlial pneumonitis. Arch Intern Med, 1984; 144:1764 - 1765.
  • 9Lee E, Miki Y, Katsura H, et al. Mechanism of inactivation of myeloperoxidase by propylthiouracil. Biochem Pharmacol, 1990;39:1467- 1471.
  • 10Kudoh Y, Kuroda S, Shimamoto K, et al. Propylthiouracil-induced rapidly progressive glomerulonephritis associated with antineutrophil cytoplasmic autoantibodies. Clin Nephrol, 1997;48:41 - 43.

同被引文献50

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部